𝔖 Bobbio Scriptorium
✦   LIBER   ✦

The hepatic circulation in health and disease: Report of a single-topic symposium

✍ Scribed by Vijay Shah; Guillermo García-Cardeña; William C. Sessa; Roberto J. Groszmann


Publisher
John Wiley and Sons
Year
1998
Tongue
English
Weight
90 KB
Volume
27
Category
Article
ISSN
0270-9139

No coin nor oath required. For personal study only.

✦ Synopsis


Blood flow and vascular resistance in the hepatic vasculature are closely regulated through a balance of vasoactive molecules including nitric oxide (NO), carbon monoxide (CO), endothelin (ET), and prostanoids such as prostacyclin. These vasoregulatory agents interact with unique nonparenchymal cells in the hepatic sinusoid through autocrine and paracrine mechanisms. These cells, which include sinusoidal endothelial cells (SEC), hepatic stellate cells (HSC), and Kupffer cells (KC), each have the molecular machinery to synthesize and/or respond to these vasoactive molecules. This complex interaction of cells and molecules, although not well understood, appears to involve vasoregulatory mechanisms that are unique to the hepatic vascular bed. Alterations in the function of the cells lining the sinusoids and in the activity of vasoactive mediators in the hepatic circulation play a role in mediating vascular disturbances which may arise in the liver secondary to cirrhosis, sepsis, and liver transplantation. Thus, understanding the mechanisms which regulate blood flow in the hepatic circulation are of vital importance. On June 21-22, 1996, the American Association for the Study of Liver Diseases sponsored a symposium entitled ''Liver Microcirculation in Health and Diseases.'' The purpose of this conference was to review current basic research endeavors pertaining to the hepatic circulation. The conference was organized into four sessions, with each session composed of several lectures. This article will summarize the salient aspects of each lecture based on summaries submitted by the speaker and modified based on dictations of the lecture. The first section, entitled ''Endothelial and Smooth Muscle Regulation of Vascular Function,'' chaired by William C. Sessa and Roberto J. Groszmann, examined basic mechanisms of vascular regulation, with particular emphasis on the physiology and biology of the endothelial cell and its modulation by other cell types, vasoactive mediators, and biomechanical forces. The second section, entitled ''The Liver Microcirculation,'' chaired by Robert S. McCuskey and Jurg Reichen, addressed anatomic and physiological studies in the hepatic circulation and novel characteristics of HSC. The third section, entitled ''Pathogenesis of Portal Hypertension,'' chaired by Jaime Bosch and Didier LeBrec, examined mechanisms that may account for the hemodynamic disturbances in the liver and other regional beds that are characteristic of chronic liver disease. The fourth section, entitled ''Sepsis and Transplantation,'' chaired by Ian R. Wanless and Andres T. Blei, discussed the mechanisms that mediate the microvascular injury often observed after liver transplantation and during sepsis.


📜 SIMILAR VOLUMES


Vascular biology and pathobiology of the
✍ Yasuko Iwakiri; Matthew Grisham; Vijay Shah 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 496 KB

Portal hypertension and its complications account for the majority of morbidity and mortality that occurs in patients with cirrhosis. In addition to portal hypertension, a number of other vascular syndromes are also of great importance, especially the ischemia-reperfusion (IR) injury. With the ident

Hepatic fibrosis 2006: Report of the thi
✍ Scott L. Friedman; Don C. Rockey; D. Montgomery Bissell 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 117 KB

The third American Associated for the Study of Liver Diseases (AASLD)-sponsored Single Topic Conference on hepatic fibrosis was held in June 2006. The conference was both international, with 6 countries represented, and cross-disciplinary, linking the basic molecular and cellular biology of fibrogen

Report on a single-topic conference on “
✍ John W. Ward; Anna S.F. Lok; David L. Thomas; Hashem B. El-Serag; W. Ray Kim 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 231 KB

and Roche and has received grants from Bristol-Myers Squibb, GlaxoSmithKline, Gilead, Roche, and Merck. David Thomas has been a consultant for Merck and has received grants from Gilead and Merck. Hashem El-Serag has been a consultant for Vertex and has received grants from Bayer and Abbott. Ray Kim